Elastography Changes in Cesarean Scar After Negative Pulsed Pressure Treatment
ELASTICFLOOR
1 other identifier
interventional
30
1 country
2
Brief Summary
The application of pulsed negative pressure to the scar tissue stimulates the cellular response, producing elastic changes in the tissue, quantifiable by ultrasound, not only in terms of thickness but also in the elastic capacity of the tissues, measured by quantified elastography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedStudy Start
First participant enrolled
October 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedOctober 25, 2023
October 1, 2023
3 months
September 12, 2023
October 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
elastography measurement
The elastography is obtained when the anatomic image on grayscale ultrasound overlaps parametric color image that expresses the rate of deformity of the tissues, soft tissues tend to develop greater deformity and tissue deformity have lower rigidity.
Time0 (T0) FIRST DAY BEFORE FIRST TREATMENT, TIME 1 (T1) FIRST DAY AFTER FIRST TREATMENT, TIME 2 (T2) AFTER 6 DAY OF TREATMENT (THE THIRD WEEK) , TIME 3(T3) 15 DAYS AFTER THE SIXTH TREATMENT, TIME 4 (T4) ONE MONTH AFTER THE SIXTH TREATMENT.
Secondary Outcomes (2)
adheremeter measurement
Time0 (T0) FIRST DAY BEFORE FIRST TREATMENT, TIME 1 (T1) FIRST DAY AFTER FIRST TREATMENT, TIME 2 (T2) AFTER 6 DAY OF TREATMENT (THE THIRD WEEK) , TIME 3(T3) 15 DAYS AFTER THE SIXTH TREATMENT, TIME 4 (T4) ONE MONTH AFTER THE SIXTH TREATMENT.
Foot posture index
Time0 (T0) FIRST DAY BEFORE FIRST TREATMENT, TIME 1 (T1) FIRST DAY AFTER FIRST TREATMENT, TIME 2 (T2) AFTER 6 DAY OF TREATMENT (THE THIRD WEEK) , TIME 3(T3) 15 DAYS AFTER THE SIXTH TREATMENT, TIME 4 (T4) ONE MONTH AFTER THE SIXTH TREATMENT.
Study Arms (1)
NEGATIVE PULSED PRESSURE INTERVENTION GROUP
EXPERIMENTALThe number of treatment sessions will consist of a total of 6 sessions, so there will be two sessions over 3 weeks. The evaluations of the participants will be carried out before and after the first session, after the last session of the treatment program received, 15 days and one month after finishing the treatment.
Interventions
For the application of pulsatile negative pressure, the AeroFlow® equipment will be used, carried out by one of the researchers participating in the project.The application will be carried out addressing the structure of interest (scar), following the protocol established by INDIBA to release adhesions between the different depth planes. The work will consist of an application of pulsed negative pressure using suction cups, which will work automatically at a frequency and intensity tolerable by the patient. Treatment protocol in 2 phases Total application time 15min 1. Static cup: preparation: Prepare the tissue surrounding the scar. 5min 2. Dynamic Cup: work: Lock the tissue around the scar and the scar itself.10min Suction mode: continuous with continuous sliding of the cup The number of treatment sessions will consist of a total of 6 sessions, so there will be two sessions over 3 weeks.
Eligibility Criteria
You may qualify if:
- Participants aged between 18 and 60 years
- Who have undergone cesarean section surgery and therefore have a scar, lasting more than six months and less than 2 years.
- Patients who present a post-cesarean section scar with a fibrotic appearance and possible surrounding fascial restrictions.
You may not qualify if:
- Patients who present any neurological, inflammatory or orthopedic injury that prevents or alters balance, listening, vision or the cognitive abilities necessary to be able to answer appropriate questions or take questionnaires.
- Patients who present keloids in the scar.
- Patients who have contraindications to be treated with a 448kHz radiofrequency device such as:
- to. pregnant women b. Subjects with any type of electronic implants. c. Subjects presenting with thrombophlebitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ana González
Málaga, 29018, Spain
Clínica Ana González
Málaga, 29018, Spain
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student, MSc
Study Record Dates
First Submitted
September 12, 2023
First Posted
September 28, 2023
Study Start
October 30, 2023
Primary Completion
February 11, 2024
Study Completion
June 30, 2024
Last Updated
October 25, 2023
Record last verified: 2023-10